Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers

NCT00183846 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Gastric Cancer
Duodenum Cancer
Bile Duct Cancer

Interventions

DRUG: irinotecan
PROCEDURE: radiation therapy

Sponsor

University of Southern California